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ABSTRACT

The female sex hormone estrogen has potent neuroprotective properties. Some of these
effects may be due to direct modulation of mitochondrial functions. I hypothesized that �
estradiol, a specific hormone of the estrogen family, will improve mitochondrial bioenergetics in
ovariectomized mice. Mice (C57BL/6J, female, 4- 10 months-old) were ovariectomized via
bilateral incision and control animals underwent sham surgery. Ovariectomized mice were
divided into two groups. One group received a subcutaneous injection of 17-�-estradiol (E2)
dissolved in com oil (30 ng/g) 24 h prior to synaptosome isolation (estradiol group). The second
group received com oil alone (OVX). Synaptosomes were isolated from the forebrain by Percoll
gradient centrifugation. Oxygen consumption of permeabilized synaptosomes was measured
using Clark-type polarographic electrodes at 37°C. Respiration rates under conditions of
oxidative phosphorylation (OXPHOS, state 3) were determined in presence of 5 mM pyruvate, 2
mM malate, 10 mM glutamate, 10 mM succinate, and 2 mM ADP. Our results revealed that
OXPHOS state 4 rates dropped in OVX mice compared to those receiving the sham surgery.
Respiration rates after estrogen treatment increased compared to OVX and were
indistinguishable from those in the sham treatment. However, no differences in OXPHOS rates
were observed among groups in absence of succinate. My data indicate that E2 directly increases
mitochondrial activity. Additional studies should attempt to determine whether succinate
dehydrogenase levels are altered by E2 administration.

2

ACKNOWLEDGMENTS

There are a number of people who have aided me tremendously throughout the course of
my research in the Menze lab. First and foremost, I would like to thank Dr. Michael Menze. He
has taken the time out of his busy schedule to teach, critique, correct, and put up with me for the
last three years. Without his assistance, I would not have been nearly as successful in my
academic pursuits. I too would like to thank Dr. Britto Nathan, not only for his help in the lab,
but also for expanding my understanding and furthering my interest in neurobiology. Lastly, I
thank the EIU Biological Sciences faculty and department as a whole, as well as the Honors
College, for providing an open learning environment and supporting undergraduate research.

3

TABLE OF CONTENTS
Title Page
Abstract

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

Acknowledgments
Table of Contents
Introduction

1

2

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . .... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ........

3

..........................................................................................................................

4

...................................................................................................................................

Materials and Methods

5

11

..................... .. ........................................................................................

14

Results

...........................................................................................................................................

Discussion

......................................................................... ........................ ....................... ...... .......

Conclusions

19

.................................................................. ................................................................

Literature Cited

................................................ ......................................................... . . . . . . ...........

21

22

4

INTRODUCTION
Alzheimer's disease (AD) is a neurodegenerative disease affecting 2% of the population
in the industrialized world (Mattson et al., 2011). AD is characterized by severe dementia,
extensive memory loss, and other observable mental changes in patients (Dickson et al., 1999).
The study of AD has led to the inclusion of several physiological changes on the cellular and
molecular levels that characterize the disease itself (Katzman, 1976). For example,
neurofibrillary tangles, twisted fragments of protein that clog up the cell, are observed in the
early stages of the disease. These tangles propagate and cause the formation of senile and
neuritic plaques, which are clusters of dead and dying nerve cells, glial cells, and protein
(Tiwari-Woodruff et

al., 2007). Dysfunctions of synaptic mitochondria have been shown to play

a key role in neuronal death, ultimately leading to an increase in plaque levels within brain tissue
(Nicholls and Budd, 2000; Swerdlow, 2006). As the efficiency of mitochondrial respiration
declines, less energy becomes available to cells, further aggravating the brain tissue (Castellani
et al., 2002). In order to combat declining mitochondrial respiration, studies have been conducted
to determine which compounds can be used to prevent mitochondrial dysfunction entirely, or
slow the decline in respiratory capacity. To date, one of the most promising compounds is
estrogen (Green et al., 2001; Simpkins, 2006; Brinton, 2008).
Beneficial roles of estrogen on brain functions have been extensively studied. Two
isomers of the estrogen molecule exist, alpha- and 17-�-estradiol (Morin et al., 2002). Alpha
estradiol is highly concentrated in the brain, and its function is not fully understood. The
concentration of 17-�-estradiol (E2), however, is fairly constant throughout the majority of the
body and is most commonly associated with the regulation of the menstrual cycle and the
development of secondary sexual characteristics in women. In addition, E2 confers
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neuroprotection and has anti-apoptotic properties in neurons (Simpkins, 2006; Brand and
Nicholls, 2011). When neuronal cultures were grown in a medium with E2 and compared to
cultures without E2, neuronal growth and intemeuronal connections drastically increased in the
culture containing the E2-fortified medium (Fig.I).

Fig. 1: Mouse neurons grown in cell culture plates. Neurons were grown in absence of
estrogen (A) and in presence of 0.1 µg E2/mL of cell culture medium (Bar= 100 µm)
(Sudo et al., 1997).
Interestingly, E2 can also been shown to assist in the stabilization of the mitochondrial
membrane potential. Therefore, the mechanisms through which E2 exhibits neuroprotective
properties might lie within the mitochondria (Hirai et al., 2001). Receptors for both alpha- and
17-beta-estradiol (ERa and ERb respectively) have been located in mitochondria, where they
bind to the D-loop of mouse and human mtDNA (mitochondrial DNA) (Chen et al., 2009). There
is a higher prevalence of ERb receptors due to a mitochondrial targeting sequence in ERb at
amino acid positions 220-270, a sequence that is absent in ERa (Cheng et al., 2004). Additional
studies indicate that ERb interaction with the genes Tom70 and Hsp70 may play a role in
mitochondrial trafficking of ERb (Simpkins, 2006).
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When mitochondria were isolated from ovariectomized rats that had been treated (in vivo)
with E2, increased respiration rates were observed ( Irwin et al., 2008). Furthermore, studies on
the changes in the mitochondrial proteome in rats revealed an increased expression of the
proteins that link glucose utilization to the TCA cycle, as well as an increased expression in a
number of electron transport system (ETS) proteins, such as subunits one to four of complex IV
(Nilsen et al., 2007). In this context, it is important to note that the activity of the ETS is tightly
linked to ATP production in the cell by oxidative phosphorylation (OXPHOS). The increased
expression of any component of this system may directly impact overall ATP production in the
cell. Understanding the process through which ATP production is achieved during OXPHOS is
important for determining how E2 may ultimately affect the progression of AD. Electrons from
NADH and FADH2 enter the respiratory system at complex I and II, respectively. Complexes I,
III, and IV function as proton pumps, moving protons from the mitochondrial matrix across the
inner membrane to the intermembrane space. In order for these complexes to pump protons,
electrons must pass between the complexes via the electron carriers ubiquinone (from complexes
I and II to complex III) and cytochrome- c (from complexes III to complex IV). The
accumulation of protons in the intermembrane space leads to a "back pressure" known as the
proton motive force (PMF). The ATP synthase complex utilizes this force by allowing protons to
flow back into the mitochondrial matrix, and in the process combines ADP and inorganic
phosphate to form ATP. This background is the foundation for testing the bioenergetic effects of
E2 on specific protein complexes.
Many studies (Nilson and Brinton, 2003; Irwin et al., 2008) used non-synaptic brain
mitochondria preparations to elucidate the mechanisms behind estrogen-mediated
neuroprotection in the brain, but this method has limitations (Klinge, 2008). First, the mixture is
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naturally heterogeneous, because the isolated non-synaptic mitochondria stem from the cells of
not only neurons, but from glia cells as well. Second, the environment in which the mitochondria
are incubated after isolation is different from the physiological conditions in vivo, in terms of
substrate availability (Nicholls and Budd, 2000). To overcome these limitations, isolated nerve
terminals (synaptosomes) can be used because they maintain functions similar to those of intact
cells in terms of metabolism, mitochondrial function, plasma membrane excitability, receptors,
ion channels, and various components of the cellular machinery for exocytosis and the reuptake
of neurotransmitters (Scott and Nicholls, 1980; Nilson and Brinton, 2003) (Fig. 2).

homogenization

dendrites

1'yn a ptosome
cell body

Fig. 2: Neuronal diagram, incorporating synaptosomal isolation.
Adapted from piercenet.com

In this study, synaptic brain mitochondria were isolated from ovariectomized mice treated
with E2 24 h prior to isolation. Preparations then underwent a series of detailed respiratory
assays to determine the effects of E2 on specific complexes of the ETS. These assays were
performed by measuring the oxygen consumption of isolated synaptosmes in the presence of
specific substrate and inhibitor combinations. The tests were carried out using a high-resolution
respirometer with various titration schemes. A standard scheme used to measure the respiration
rates of maximally energized mitochondria is as follows: the titration of the permeabilizing agent
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digitonin to the synaptosome suspension is followed by the substrates malate, glutamate,
pyrtivate, ADP, and succinate, and finally the inhibitors oligomycin and antimycin-A are added
(Fig.3).
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Fig. 3: Example Oroboros Oxygraph 2K trace, including titration scheme.

The left y-axis that scales the blue line is a measure of the oxygen concentration in the
chamber of the respirometer. The right y-axis corresponds to the red line, the derivative of the
blue line, measuring the rate at which oxygen in the chamber is consumed. Any increase in the
red line indicates an increase in mitochondrial respiration. The x-axis is the duration of the
experiment in minutes. At the onset of every titration scheme, digitonin is used to permeabilize
the plasma membrane of the synaptosomes, allowing access to the mitochondria for the
remainder of the experiment. Malate, glutamate, and pyruvate (MGP) are metabolized to
generate NADH, thereby functioning as complex I substrates, and after their addition a slight
increase in oxygen consumption is observed. The addition of ADP then enables complex V
(F0F 1-ATP-synthase) to generate ATP. Addition of ADP allows the backflow of protons into the
matrix and increases mitochondrial respiration. To maximally energize the mitochondria,
succinate is added (a complex I I substrate) and another increase in respiration is observed. In
order to observe the "leak-respiration," the backflow of protons that does not engage the ATP-
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synthase, oligomycin is added. Oligomycin binds to the ATP-synthase and prevents protons from
entering the matrix, thus reducing respiration levels to that of an ADP-free environment.
Antimycin-A is added last, to shut down the ETS by binding to the ubiquinone receptor site of
complex III. This allows any non-mitochondrial respiration to be observed and accounted for.
In the study presented here, I demonstrate that through titration schemes such as these,
differences in activity were observed in complex II of the ETS after E2 administrations. E2
ameliorated the decline in respiration induced by ovariectomy, which leads to the removal of
endogenous estrogen.
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MATERIALS AND METHODS
Ovariectomy

Ovaries were surgically removed from 4-10 month old female wild-type mice
(C57BL/6J) according to the following procedure. Each mouse received a 40µL injection of
ketamine intraperitonially to induce sedation. The lower mid-dorsal region was then clipped and
prepared for aseptic surgery. A 1 cm incision was made along the skin, and after the skin was
separated a second incision was made halfway down the side of the abdominal wall allowing
access to the abdominal cavity in the region of the periovarian fat pad. The ovary was isolated
using tissue forceps to exteriorize the ovarian fat pad, and then excised between the uterine horn
and fallopian tube. The abdominal and skin incisions were closed using surgical glue and the
procedure was then repeated for the other side of the subject.
Treatment Groups

C57BL/6J mice were randomly divided into three groups. Group 1 (Sham) was
comprised of mice that had undergone sham ovariectomy surgery in order to test for any possible
bioenergetic or physiological changes simply as a result of the bilateral incisions. Group 2 mice
(OVX) underwent ovariectomy, and after two weeks of recovery, received a subcutaneous
injection of com oil, the solvent used to bring E2 into solution. Group 3 mice were
ovariectomized, and received a subcutaneous injection of E2 (30 ng/g) after a two-week recovery
period.
Synaptic Mitochondrial Isolation

Brain synaptosomes were isolated 24h post-treatment from all groups. The mouse
forebrain was removed, washed, and homogenized in an isolation medium (IM) consisting of
sucrose (225 mM), mannitol (75 mM), EGTA (1 mM), HEPES (5 mM), and 1 g/L BSA adjusted
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to pH 7.4 with Tris base (Sigma-Aldrich, St. Louis, MO). Tissue subfractionation was achieved
via centrifugation first at 1300g in IM, and second in a 15/24/40% Percoll gradient at 30,700 g.
The remaining tissues consisted ofmyelin, synaptosomes, and pure mitochondria, in the
15/24/40% Percoll sections, respectively. The resulting synaptosomal fraction was washed twice
in IM, and stored on ice until assayed.
Respirometry

Respiration was measured at 37°C using 10-20 µL isolated synaptosomes in each
respiratory chamber ofan Oxygraph-2K (OROBOROS Instruments, Innsbruck, Austria).
Respiration ofpermeabilized synaptosomes was measured in 2 mL ofMIR05 (110 mM sucrose,
60 mM potassium lactobionate, 20 mM taurine, 10 mM KH2P04, 3 mM MgC12, 0.5 mM
EGTA, 0.1 % BSA, 20 mM HEPES-KOH , pH 7. 1) before and after addition of inhibitors or
uncouplers. DATLAB software (OROBOROS Instruments) was used for data analysis and
acquisition.
OXPHOS Analysis

Synaptosomes were permeabilized through the addition ofdigitonin dissolved in DMSO
at 10 mg/ml. This concentration was chosen after several titrations with digitonin, and found to
be sufficient to permeabilize the synaptosome plasma membrane with the lowest possible impact
on the outer mitochondrial membrane (OMM). At the given digitonin concentration, additional
injections ofdigitonin did not increase oxygen flux ofadenosine diphosphate (ADP) stimulated
respiration, and addition ofcytochrome-c ( 10 µg/ml) led to only minor increases in respiration
rates.
Three major titration schemes were performed on all treatment groups. The first tested
complex I and 'membrane leakiness' ofthe ETS through the addition ofmalate (2 mM),
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glutamate (10 mM), and pyruvate (5 mM), after synaptosomes were permeabilized with digitonin
(10 µg). Maximal respiration of the ETS was then observed after the addition of ADP (3 mM)
and succinate ( 10 mM). Oxygen consumption after inhibition of mitochondrial respiration was
recorded in presence of antimycin A (2.5 µM). The second titration scheme compared states 2, 3,
and 4 respiration through the additions of 2 mM malate, 10 mM glutamate, 5 mM pyruvate, and
10 mM succinate. To induce oxidative phosphorylation (OXPHOS) 1 mM ADP was added. The
third titration tested the activity of complex II alone. This was accomplished through the addition
of rotenone (0.5 µM), followed by succinate, ADP, and oligomycin. Residual oxygen
consumption (non-mitochondrial respiration) was recorded in all titrations after the addition of
2.5 µM antimycin A. Sample sizes for each treatment varied from 6-14 because of mouse type
availability as well as having the time to carry out all titration schemes consecutively.
Protein Quantification

Standard Bradford protein assays could not be run on the synaptosome samples because
of the known interactions of Percoll with the Bradford reagents. Instead a Lowry protein assay
was used (Lowry et al., 1951).
Statistical Analysis

Statistical differences were determined through analysis of variance (ANOVA).
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RESULTS

To determine the effect(s) of 17-�-estradiol (E2) on the bioenergetics of the synaptic
mitochondria, each complex of the electron transport system (ETS) was evaluated. The state 3
(ADP-stimulated) respiration of complex I in the presence of malate, glutamate, pyruvate, ADP,
1
and succinate was reduced in OVX mice (mean± 1 SE, 5.55± 0.32 02•s_ 1• µg- protein;
compared to Sham (7.00 ± 0.28 pmol 02·s- 1• µg- 1 protein;

n =

n =

14)

8, p < 0.05). In addition, after �-

1
1
estradiol treatment, state 3 respiration rates were higher (6.96± 0.53 02·s- •µg- protein;

n =

6, p

< 0.05) compared to OVX, and were similar to state 3 rates in Sham mice (p > 0.05). In the
absence of succinate however, no differences among state 3 rates were observed (Fig. 4).

Figure

4.

Oxygen flux of permeabilized synaptosomes of Sham, OVX, and �-estradiol treated mice during

state 3 (ADP-stimulated OXPHOS) respiration with and without the addition of succinate. Different
letters indicate values that differ from each other (p

< 0.05).
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After testing maximum (state 3) respiration in the presence of substrates that engage
complex I, the state 20 or "leak" respiration was measured in order to determine the extent of
proton backflow from the mitochondrial inter-membrane space to the mitochondrial matrix.
Similar to state 3 respiration, state 20 (in presence of oligomycin) rates showed a significant
1
decrease in OVX treated mice ( 1.18± 0.052 02·s-1• µg- protein;
1
1
(1.5 1 ± 0.043 02·s- • µg- protein;

n =

n =

13) compared to Sham

8), and a significant increase above OVX was observed

1
1
when mice were treated with P-estradiol (2.09± 0.39 02·s- • µg- protein;

n =

13, p < 0.05) (Fig.

5).
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Because of the differences noted in the presence of succinate, a complex II exclusive
substrate, I decided to assess complex II by itself. For complex I I of the ETS, the state 2
respiration in the presence of P-estradiol was higher (1.464 ±0.07 0.043 02·s-1• µg-1 protein;
1
6) than OVX respiration levels (0.943 ±0.04 0.043 02·s- • µg-1 protein;
were lower than Sham (1.323 ±0.05 0.043 02·s- 1• µg- 1 protein;

n =

n =

n =

6, p < 0.05), which

6, p < 0.05). State 3

respiration exhibited similar patterns (Fig. 6).
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Complex I state 2o "leak" respiration (measured in the presence of substrates M+G+P) of
1
1
OVX (0.425 ± 0.025 02·s- • µg- protein;

n

=

1
14) and Sham (0.402 ± 0.033 02·s-1 • µg- protein;

n

8) were similar. When treated with P-estradiol, however, state 20 respiration rate increased

=

1
1
(0.629 ± 0.032 02·s- • µg- protein;

n

=

6, p < 0.05) compared to both OVX and Sham (Fig. 7).

0.7

B

......._

c:

"Q)

0.6

0
I...

c..

�
'

O>
::i

0.5
A

it

"';
(/)
it

N
O

A

0.4

0

E

c..

0.3

'-"

><
:J
LL
c:
Q)

�

0

0.2

0.1

0.0
Sham

ovx
Treatment Groups

�-est

Figure 7: Oxygen flux of permeabilized synaptosomes of Sham, OVX, and �-estradiol treated mice
during state
<

2 respiration (M+G+P). Different letters indicate values that are different from each other (p

0.05).

17

In order to understand how efficient the ETS performed as whole, I determined the
respiratory control ratio (RCR) for each treatment group. An RCR is a comparison of respiration
with and without the presence of ADP, thus indicating the overall health of the mitochondria. A
higher RCR corresponds to better-coupled mitochondria, in regards to how well it utilizes
substrates in order to ultimately generate ATP. Sham and OVX mice RCR values were similar
(1 1.0
(7.9

+

+

0.29 and 10.6

0.36;

n =

+

0.41, respectively), but mice treated with P-estradiol had lower values

12-24) (Table 1).

Table 1. Respiratory control ratios (RCR) of permeabilized synaptosomes isolated from of Sham, OVX,
and �-estradiol treated mice (mean± SE; n =

12-24).

*

Indicates statistically significant differences (p <

0.05).

Treatment

Respiratory Control Ratio
(RCR)

Sham

11.0± 0.29

ovx

10.6± 0.41

/J-estradiol

7.9± 0.36

*
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DISCUSSION

The goal of this study was to determine the effects of �-estradiol (E2) on the
bioenergetics of synaptic mitochondria. Through E2 injections, synaptosome isolations, and the
administration of digitonin prior to the titration of substrates and inhibitors, the impact of E2 on
mitochondrial functions could directly be investigated. Various titration schemes allowed each
complex of the ETS to be evaluated for changes as a result of the E2 injections.
With the addition of �-estradiol, an increase in state 3 respiration was observed in
maximally energized synaptosomes (Fig. 4). This may point to a possible mechanism through
which reactive oxygen species (ROS) production may be reduced in the presence of estrogen: the
fact that the inner mitochondrial membrane (IMM) is more permeable in the presence of
estrogen, or "leaky," might allow a higher backflow of protons from the inter-membrane space to
the mitochondrial matrix and thereby reduces the mitochondrial membrane potential and the
amount of toxic ROS production (Smith et al., 2000).
State 3 respiration in the presence of succinate was higher compared to OVX mice, and
was similar to Sham mice. The decrease in the respiratory control rate (RCR) of �-estradiol
treated mice, when compared to OVX or Sham, was unexpected (Table 1). Leak was measured
in highly energized mitochondria however, and leak respiration under low substrate flux might
be substantially lower (Choi et al., 2009). When viewed in light of the rest of the data, this
decrease seems confusing. However, a modest decrease in RCR may not necessarily indicate a
bioenergetic problem considering the state 3 respiration rates remained at or above OVX levels.
This reduction in RCR may also contribute to the lower ROS production observed in other
studies with estradiol treatments (Brinton 2008). Typically a higher RCR is favored because it
means the ETS is functioning at higher efficiency. As the ETS generates ATP, a small amount of
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ROS is produced in the process. Consequently, a higher RCR might actually produce more ROS
than a lower RCR. This reinforces the possible mechanism of estrogen-mediated
neuroprotection. The percent increase in respiration observed after the addition of succinate
indicates a second possible mechanism through which E2 might confer some neuroprotective
effects: activity or amount of succinate dehydrogenase, or complex II of the ETS may be
upregulated in response to the hormone. After the addition of succinate (the substrate of complex
11), respiration rates in mice treated with E2 increased from OVX levels (Fig. 4,6). None of the
other ETS complexes showed a change in activity, leading me to hypothesize that the activity of
complex II within synaptosomes is a relevant target of estradiol-mediated neuroprotection.
Further tests should be conducted to determine whether estrogen treatment simply
increases the amount of complex II, or if it increases the activity of the existing complexes.
Furthermore, additional tests should be conducted to determine whether the amount of ROS
generated from the ETS decreases after the administration of E2.
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CONCLUSIONS

The major conclusions of this study can be summarized as follows:
(1) Administration of estrogen of at 30 ng/g induced increases in mitochondrial respiration.
(2) �-estradiol increases "leak" respiration, possibly reducing ROS production in the process.
(3) The maximal respiration (state 3, OXPHOS) declined after ovariectomy, but was ameliorated
by the administration of �-estradiol.
(4) The mechanism through which estrogen-mediated neuroprotective effects occur is most
likely thought action on complex II, succinate dehydrogenase, of the ETS.
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